Axsome Therapeutics reports preliminary 2025 revenue of $638.5 million

Go back to Axsome Therapeutics reports preliminary 2025 revenue of $638.5 million
(NASDAQ: AXSM) Delayed: 206.78 -0.99 (0.48%)
Previous Close $207.77    52 Week High $15.74 
Open $207.00    52 Week Low $5.37 
Day High $208.09    P/E N/A 
Day Low $205.52    EPS $0.00 
Volume 12,213